Jonathan Compton Joins Psychemedics Corporation as Director of Marketing

ACTON, Mass., Jan. 22 /PRNewswire-FirstCall/ -- Psychemedics Corporation
(Amex: PMD) today announced that Jonathan Compton has joined the company as
Director of Marketing.
Jonathan will be responsible for all marketing activities, as well as
establishing, staffing and directing the company's lead generation program.
Jonathan will report directly to the Chairman and CEO.
Since 1999, Jonathan has served as Director of Marketing for DeWolff,
Boberg and Associates, a management consulting firm where he recruited,
trained and managed a twelve person inside sales team that generated leads for
the outside sales force. From 1995 to 1999, Jonathan was a manager for Arthur
Andersen LLP's National Specialty Team for Family Wealth Planning where he
managed inside sales that generated meetings with high net worth clients for
Arthur Andersen's tax partners and managers in the U.S. Prior to his position
at Arthur Andersen, Jonathan ran inside sales and outside sales for ITAC
Systems as well as serving as Marketing Director for Whitehall Group/Heritage
Organization LLC. Jonathan has his B.S.E.E. from the University of Texas,
Arlington.
Raymond C. Kubacki, Chairman and CEO stated, "We are extremely pleased to
have Jonathan join our team. He comes to us with a strong proven track record
that fits extremely well with the needs of our company. His lead generation
expertise as well as his other broad marketing capabilities will play a key
role in our company's objective to accelerate our sales growth. We are
excited to have Jonathan on board."
Psychemedics is the world's largest provider of testing for drugs of abuse
using hair analysis with thousands of corporations relying on the patented
Psychemedics drug testing services. Psychemedics' clients include over 10% of
the Fortune 500, some of the largest police departments in America and Federal
Reserve Banks.
The Psychemedics web site is http://www.drugtestwithhair.com
Cautionary Statement for purposes of the "safe harbor" provisions of the
Private Securities Litigation Reform Act of 1995: From time to time,
information provided by Psychemedics may contain forward-looking information
that involves risks and uncertainties. In particular, statements contained in
this release that are not historical facts (including but not limited to
statements concerning growth, earnings, profit margins, earnings per share,
revenues, dividends, future business, new accounts, customer base, market
share, test volume and sales and marketing strategies) may be "forward
looking" statements. Actual results may differ from those stated in any
forward-looking statements. Factors that may cause such differences include
but are not limited to risks associated with the expansion of the Company's
sales and marketing network, development of markets for new products and
services offered, the economic health of principal customers of the Company,
government regulation, including but not limited to FDA regulations,
competition and general economic conditions and other factors disclosed in the
Company's filings with the Securities and Exchange Commission.
Contact: Raymond C. Kubacki
Chairman, President and CEO
(978) 206-8220

SOURCE Psychemedics Corporation

Raymond C. Kubacki, Chairman, President and CEO of Psychemedics Corporation,
+1-978-206-8220